<DOC>
	<DOCNO>NCT01610440</DOCNO>
	<brief_summary>Duchenne muscular dystrophy ( DMD ) , X-linked recessive genetic disease always progress slowly，tends lead proximal skeletal muscle atrophy weakness limb , well impaired respiratory muscle cardiac muscle . To large extent , patient always lose motor function gradually die heart failure severe infection end stage DMD . At present , treatment strategy rely heteropathy accompany rehabilitation training . However , therapeutic effect remain extremely limited . Human umbilical cord mesenchymal stem cell ( hUC-MSCs ) evidence improve motor function , increase muscle strength reduce abnormal level relate enzymes , creatine kinase ( CK ) , lactate dehydrogenase ( LDH ) , alanine aminotransferase ( ALT ) aspartate aminotransferase ( AST ) . This study aim explore safety efficacy hUC-MSCs transplantation DMD .</brief_summary>
	<brief_title>Safety Efficacy Umbilical Cord Mesenchymal Stem Cell Therapy Patients With Duchenne Muscular Dystrophy</brief_title>
	<detailed_description>This study design investigate safety efficacy human umbilical cord mesenchymal stem cell transplantation patient progressive muscular dystrophy .</detailed_description>
	<mesh_term>Muscular Dystrophies</mesh_term>
	<mesh_term>Muscular Dystrophy , Duchenne</mesh_term>
	<criteria>Aged 512 year Clinical manifestation , enzymology , electromyogram , gene type confirm diagnose Duchenne muscular dystrophy Sign consent form follow clinic trail procedure Not Duchenne muscular dystrophy Any history hypersensitivity serum product , know drug food allergy Combined Pneumonia Severe systemic bacteria infection HIV+ , TPPA +， patient diagnose HBV HCV Tumor Markers + Severe psychotic patient , cognitive dysfunction Coagulation disorder Uncontrolled hypertension treatment，blood pressure≥180mmHg/110 mmHg Other severe systemic organic disease Enrollment trial last 3 month Received stem cell therapy past 6 month Other criterion investigator consider improper inclusion</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Duchenne muscular dystrophy</keyword>
	<keyword>Human Umbilical Cord Mesenchymal Stem Cells</keyword>
</DOC>